Bio­Mo­tiv, Bris­tol-My­ers al­liance bears fruit with new com­pa­ny: An­teros Phar­ma

As a phar­ma­ceu­ti­cal ac­cel­er­a­tor that se­lects and in­cu­bates nascent tech­nol­o­gy from the halls of acad­e­mia, Bio­Mo­tiv is con­stant­ly in need of fund­ing. En­ter Bris­tol-My­ers Squibb …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER